688068 logo

Beijing Hotgen Biotech XSSC:688068 Stock Report

Last Price

CN¥83.24

Market Cap

CN¥7.5b

7D

-10.8%

1Y

166.5%

Updated

14 Mar, 2025

Data

Company Financials +

Beijing Hotgen Biotech Co., Ltd.

XSSC:688068 Stock Report

Market Cap: CN¥7.5b

688068 Stock Overview

Engages in the research, development, manufacture, and sale of medical and public safety inspection products of in-vitro diagnostic products in the field of biomedicine. More details

688068 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth5/6
Past Performance0/6
Financial Health6/6
Dividends0/6

Rewards

Earnings are forecast to grow 124.95% per year

Risk Analysis

Highly volatile share price over the past 3 months compared to the CN market


Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

Beijing Hotgen Biotech Co., Ltd. Competitors

Maccura BiotechnologyLtd

SZSE:300463

CN¥8.9b

Novogene

SHSE:688315

CN¥7.0b

Shanghai Medicilon

SHSE:688202

CN¥4.7b

Shanghai Runda Medical Technology

SHSE:603108

CN¥13.7b

Price History & Performance

Summary of share price highs, lows and changes for Beijing Hotgen Biotech
Historical stock prices
Current Share PriceCN¥83.24
52 Week HighCN¥99.18
52 Week LowCN¥22.94
Beta1.62
1 Month Change30.51%
3 Month Change49.10%
1 Year Change166.45%
3 Year Changen/a
5 Year Changen/a
Change since IPO63.54%

Recent News & Updates

Recent updates

Shareholder Returns

688068CN Life SciencesCN Market
7D-10.8%-3.4%-0.9%
1Y166.5%10.5%12.5%

Return vs Industry: 688068 exceeded the CN Life Sciences industry which returned 10.5% over the past year.

Return vs Market: 688068 exceeded the CN Market which returned 12.5% over the past year.

Price Volatility

Is 688068's price volatile compared to industry and market?
688068 volatility
688068 Average Weekly Movement11.2%
Life Sciences Industry Average Movement6.3%
Market Average Movement6.1%
10% most volatile stocks in CN Market10.3%
10% least volatile stocks in CN Market3.4%

Stable Share Price: 688068's share price has been volatile over the past 3 months compared to the CN market.

Volatility Over Time: 688068's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of CN stocks.

About the Company

FoundedEmployeesCEOWebsite
2005950Changqing Linwww.hotgen.com.cn

Beijing Hotgen Biotech Co., Ltd. engages in the research, development, manufacture, and sale of medical and public safety inspection products of in-vitro diagnostic products in the field of biomedicine. It offers drug detection, CDC, Up-conversion luminescence technology, colloidal gold, CLIA, sugar capture, microfluidic, and gene detection products for testing of intestinal microorganisms, gastrointestinal foodborne infections, insect-borne diseases, respiratory pathogens, infectious diseases, Ebola virus antigen, biological warfare agents, microorganisms, and mycotoxins. Beijing Hotgen Biotech Co., Ltd.

Beijing Hotgen Biotech Co., Ltd. Fundamentals Summary

How do Beijing Hotgen Biotech's earnings and revenue compare to its market cap?
688068 fundamental statistics
Market capCN¥7.46b
Earnings (TTM)-CN¥179.23m
Revenue (TTM)CN¥510.89m

14.6x

P/S Ratio

-41.6x

P/E Ratio

Is 688068 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
688068 income statement (TTM)
RevenueCN¥510.89m
Cost of RevenueCN¥0
Gross ProfitCN¥510.89m
Other ExpensesCN¥690.12m
Earnings-CN¥179.23m

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

Apr 30, 2025

Earnings per share (EPS)-2.00
Gross Margin100.00%
Net Profit Margin-35.08%
Debt/Equity Ratio0%

How did 688068 perform over the long term?

See historical performance and comparison

Dividends

0.2%

Current Dividend Yield

-27%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/03/14 21:14
End of Day Share Price 2025/03/14 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Beijing Hotgen Biotech Co., Ltd. is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Bin WuChina Merchants Securities Co. Ltd.
Xinming ZhouTopsperity Securities